2 completed, 2 recruiting. 2 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Antagonist: new trials by email Literature Review of Antagonist trials Research Report on Antagonist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) Follitropin alfa/lutropin alfa (MBJ-0011), hMG, Cetrorelix acetate - Infertility | Phase 3 | Recruiting | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 266 | 2026-02-05 | 2026-10-29 |
| Ovarian Hyperstimulation Syndrome Prevention Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ - Ovarian Hyper Stimulation Syndrome (OHSS) | Not applicable | Recruiting | Aljazeera Hospital | 300 | 2024-11-17 | 2024-12-18 |
| Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS Gonadotropin, Antagonist - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | ClinAmygate | 300 | 2019-07-01 | 2019-11-21 |
| Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation Bravelle and Menopur, Agonist, Antagonist - Fertility | Not applicable | Completed | Main Line Fertility Center | 43 | 2012-07-01 | 2014-06-04 |
Infertility (1) · Lymphoma, Follicular (1) · Ovarian Hyperstimulation Syndrome (1)
Aljazeera Hospital (1) · ClinAmygate (1) · Main Line Fertility Center (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)
Egypt (2) · Japan (1) · United States (1)
Eman Elgendy, MD (1) · Mahmoud Alalfy, MD (1) · Michael J Glassner, M.D. (1) · Sharon H. Anderson, Ph.D (1)